Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class
July 24, 2024
July 24, 2024
CAMBRIDGE, Massachusetts, July 24 -- Flagship Pioneering, a bioplatform innovation company, issued the following news release:
* * *
The Abiologics platform leverages cutting-edge generative AI and high throughput chemical protein synthesis to create Synteins(TM), a new class of programmable medicines that aims to redefine what therapeutics can achieve for patients
The company emerges after 3 years of platform development and an initial commitment of $50 mi . . .
* * *
The Abiologics platform leverages cutting-edge generative AI and high throughput chemical protein synthesis to create Synteins(TM), a new class of programmable medicines that aims to redefine what therapeutics can achieve for patients
The company emerges after 3 years of platform development and an initial commitment of $50 mi . . .